Literature DB >> 22921696

Abnormalities of 24-hour urine composition in first-time and recurrent stone-formers.

Brian H Eisner1, Sonali Sheth, Stephen P Dretler, Benjamin Herrick, Vernon M Pais.   

Abstract

OBJECTIVE: To examine differences in 24-hour urine composition between recurrent and first-time stone-formers.
METHODS: A retrospective review of patients evaluated in 2 metabolic stone clinics was performed. Recurrent stone formation was defined as patients with a history of more than 1 stone episode and first-time stone-formers were those with a history of a single-stone episode. Frequencies of urine metabolic abnormalities were noted. Multivariate linear regression was performed to evaluate the likelihood of abnormalities of 24-hour urine composition.
RESULTS: Three-hundred eleven patients met inclusion criteria: 71 (22.8%) were first-time stone-formers and 240 (77.1%) were recurrent stone-formers. On univariate analysis, the likelihood of having a single abnormality of 24-hour urine composition (ie, hypercalciuria, hyperoxaluria, hyperuricosuria, or hypocitraturia) was similar between the 2 groups (83.1% for first-time vs 88.8% for recurrent, P = NS). In addition, there were similar rates of hypercalciuria (39.4% vs 43.3%, P = NS), hyperoxaluria (32.4% vs 33.3%, P = NS), hyperuricosuria (29.6% vs 23.3%, P = NS), and hypocitraturia (45.0% vs 45.0%, P = NS). On multivariate logistic regression, there was no difference in detection of any urine abnormality (ie, hypercalciuria or hyperoxaluria or hypocitraturia or hyperuricosuria) between first-time (referent) or recurrent stone-formers (OR 1.68, 95% CI .8-3.5, P = .2).
CONCLUSION: In this study, detection of urine abnormalities was similar in first-time and recurrent stone-formers. Given the strong patient preference for stone prevention and the high success of directed therapy in the literature, we believe it is not unreasonable to offer comprehensive metabolic evaluation to first-time stone-formers who express a desire to undergo evaluation.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22921696     DOI: 10.1016/j.urology.2012.06.034

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  19 in total

1.  Update on the evaluation of repeated stone formers.

Authors:  Adam O Kadlec; Thomas M Turk
Journal:  Curr Urol Rep       Date:  2013-12       Impact factor: 3.092

2.  Parsley! Mechanism as antiurolithiasis remedy.

Authors:  Fayed Al-Yousofy; Hussein Gumaih; Hassan Ibrahim; Afrah Alasbahy
Journal:  Am J Clin Exp Urol       Date:  2017-11-09

3.  CUA guideline on the evaluation and medical management of the kidney stone patient - 2016 update.

Authors:  Marie Dion; Ghada Ankawi; Ben Chew; Ryan Paterson; Nabil Sultan; Patti Hoddinott; Hassan Razvi
Journal:  Can Urol Assoc J       Date:  2016-11-10       Impact factor: 1.862

4.  Should metabolic evaluation be performed in patients with struvite stones?

Authors:  Muhammad Waqas Iqbal; Richard H Shin; Ramy F Youssef; Adam G Kaplan; Fernando J Cabrera; Jonathan Hanna; Charles D Scales; Michael N Ferrandino; Glenn M Preminger; Michael E Lipkin
Journal:  Urolithiasis       Date:  2016-05-30       Impact factor: 3.436

5.  Risk of fracture in urolithiasis: a population-based cohort study using the health improvement network.

Authors:  Michelle R Denburg; Mary B Leonard; Kevin Haynes; Shamir Tuchman; Gregory Tasian; Justine Shults; Lawrence Copelovitch
Journal:  Clin J Am Soc Nephrol       Date:  2014-10-23       Impact factor: 8.237

6.  Calcium urolithiasis course in young stone formers is influenced by the strength of family history: results from a retrospective study.

Authors:  Angela Guerra; Andrea Ticinesi; Franca Allegri; Antonio Nouvenne; Silvana Pinelli; Fulvio Lauretani; Marcello Maggio; Gianfranco Cervellin; Loris Borghi; Tiziana Meschi
Journal:  Urolithiasis       Date:  2016-12-09       Impact factor: 3.436

7.  CT-related parameters and Framingham score as predictors of spontaneous passage of ureteral stones ≤ 10 mm: results from a prospective, observational, multicenter study.

Authors:  Ismail Selvi; Numan Baydilli; Turgut Tursem Tokmak; Emre Can Akinsal; Halil Basar
Journal:  Urolithiasis       Date:  2020-09-27       Impact factor: 3.436

8.  Dietary management of idiopathic hyperoxaluria and the influence of patient characteristics and compliance.

Authors:  Zeyad R Schwen; Julie M Riley; Yaniv Shilo; Timothy D Averch
Journal:  Urology       Date:  2013-09-17       Impact factor: 2.649

9.  24-h urine metabolic profile: is it necessary in all kidney stone formers?

Authors:  Yasmin Abu-Ghanem; Asaf Shvero; Nir Kleinmann; Harry Z Winkler; Dorit E Zilberman
Journal:  Int Urol Nephrol       Date:  2018-06-06       Impact factor: 2.370

Review 10.  Kidney stones.

Authors:  Saeed R Khan; Margaret S Pearle; William G Robertson; Giovanni Gambaro; Benjamin K Canales; Steeve Doizi; Olivier Traxer; Hans-Göran Tiselius
Journal:  Nat Rev Dis Primers       Date:  2016-02-25       Impact factor: 52.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.